Beijing Strong Biotechnologies,Inc. (SHE:300406)
China flag China · Delayed Price · Currency is CNY
11.71
+0.31 (2.72%)
Sep 21, 2026, 3:04 PM CST

SHE:300406 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Equivalents
505.27539.651,043724.04340.72382.52
Short-Term Investments
285.24321.488.4152.2325.3310.01
Cash & Short-Term Investments
790.51861.051,131876.24666.05392.53
Cash Growth
-24.10%-23.87%29.08%31.56%69.68%-34.83%
Accounts Receivable
1,0431,0601,1651,1981,039948.99
Other Receivables
46.4310.2214.477.984.84103.76
Receivables
1,0891,0711,1791,2061,1241,053
Inventory
193.09187.11220.68229.74219.65252.01
Other Current Assets
36.0780.8950.2722.556.9343.65
Total Current Assets
2,1092,2002,5812,3342,0671,741
Property, Plant & Equipment
518.57546581.77555.24438.93366.19
Long-Term Investments
615.6678.02597.61472.73300.74397.77
Goodwill
1,4981,4981,6731,6731,6731,673
Other Intangible Assets
49.9556.0657.0860.4965.8373.84
Long-Term Accounts Receivable
6.514.596.1126.314.8233.12
Long-Term Deferred Tax Assets
51.7443.4334.6745.8537.7331.33
Long-Term Deferred Charges
1.311.531.922.853.323.33
Other Long-Term Assets
21.5125.3228.565.4812.450.66
Total Assets
4,8725,0525,5615,1764,6134,320

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Accounts Payable
47.7951.9369.2981.7137.6547.14
Accrued Expenses
69.5351.2482.82108.2199.7107.35
Short-Term Debt
0.170.060.11-81.04163.46
Current Portion of Long-Term Debt
-8.4137.912.831.74192.99
Current Portion of Leases
1.571.271.461.132.020.73
Current Income Taxes Payable
24.2128.4333.4823.1420.5326.16
Current Unearned Revenue
19.3715.320.2718.9520.5719.43
Other Current Liabilities
15.3214.6632.7961.1334.6950.35
Total Current Liabilities
177.96171.32278.13297.12297.94607.6
Long-Term Debt
1,0801,0641,1241,1271,017766.4
Long-Term Leases
4.174.085.254.911.040.91
Long-Term Unearned Revenue
21.624.0528.1316.9718.6520.45
Long-Term Deferred Tax Liabilities
5.756.237.138.459.8210.98
Total Liabilities
1,2901,2701,4421,4541,3441,406

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Common Stock
586.31586.31588.33588.45588.84588.98
Additional Paid-In Capital
345.4347.38382.02399.95392.12487.69
Retained Earnings
2,5662,7633,0992,6682,2031,873
Treasury Stock
-57.72-57.84-93.63-109.59-93.07-74.8
Comprehensive Income & Other
148.35148.83149.2177.3179.98-0.54
Total Common Equity
3,5883,7884,1253,7253,2712,874
Minority Interest
-5.95-5.16-5.57-3.04-2.4439
Shareholders' Equity
3,5823,7834,1193,7223,2692,913
Total Liabilities & Equity
4,8725,0525,5615,1764,6134,320

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Total Debt
1,0861,0781,1681,1361,1021,124
Net Cash (Debt)
-295.8-216.67-37.2-259.39-436.45-731.96
Net Cash Growth
------
Net Cash Per Share
-0.50-0.37-0.06-0.44-0.71-1.25
Filing Date Shares Outstanding
581.67596.51537.21559.57568.93588.98
Total Common Shares Outstanding
581.67596.51537.21559.57568.93588.98
Working Capital
1,9312,0282,3032,0371,7691,133
Book Value Per Share
6.176.357.686.665.754.88
Tangible Book Value
2,0402,2342,3951,9921,5331,128
Tangible Book Value Per Share
3.513.754.463.562.691.92
Buildings
517.39517.58518.07288.33288.33280.47
Machinery
310.56313.94297.51262.57249.98244.43
Construction In Progress
---211.0374.820.08